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1. INTRODUCTION {#ccr32694-sec-0001}
===============

A case of a 53‐year‐old male submitted to two different bariatric surgeries without having any preoperative endocrine study. Afterward, the patient was diagnosed with Cushing\'s syndrome and severe osteoporosis. Timely diagnosis and treatment of both conditions could have prevented the surgical procedures and resulting comorbidities.

Bariatric surgery (BS) is indicated for patients with severe obesity,[1](#ccr32694-bib-0001){ref-type="ref"} and this condition is a very common clinical manifestation of Cushing\'s syndrome (CS).[2](#ccr32694-bib-0002){ref-type="ref"} Prior to the procedure, all patients should undergo preoperative evaluation for obesity‐related comorbidities and causes of obesity. If suspected clinically, screening for CS is recommended with 1 mg overnight dexamethasone test, 24‐hour urinary free cortisol, or midnight salivary cortisol.[1](#ccr32694-bib-0001){ref-type="ref"}

Cushing\'s syndrome comprises a large group of signs and symptoms that reflect prolonged and inappropriately high exposure of tissue to glucocorticoids. Although the most common cause of CS is iatrogenic, derived from prescription corticosteroids, endogenous CS could also account for a proportion of cases, being deemed as an uncommon disorder.[2](#ccr32694-bib-0002){ref-type="ref"} If the cause is endogenous, Cushing\'s disease accounts for most of the cases.[3](#ccr32694-bib-0003){ref-type="ref"} Osteoporosis affects approximately 20%‐40% of patients with CS, which is manifestly less prevalent than other comorbidities. This may result in diagnostic and treatment delay of this condition.[4](#ccr32694-bib-0004){ref-type="ref"} It is also important to bear in mind that all men diagnosed with osteoporosis should be evaluated for secondary causes of bone loss.[5](#ccr32694-bib-0005){ref-type="ref"}

The aim of this case report is to emphasize that it is essential, prior to the surgical treatment of obesity, that the patient is evaluated for secondary causes of obesity. We also intend to highlight osteoporosis as a serious complication of CS and the need to screen for the condition of all patients with hypercortisolism.

2. CASE HISTORY {#ccr32694-sec-0002}
===============

A 53‐year‐old male referred to the Endocrinology outpatient department after undergoing BS. He was professionally active as construction worker and his medical history was relevant to obesity (BMI 45.7 kg/m^2^), hypertension, chronic pain, a 70‐pack‐year smoking history and two BS, adjustable gastric banding (12 years prior), and Roux‐en‐Y gastric bypass (1 year earlier). His current medication included lisinopril, acemetacin, tapentadol, and duloxetine. One month earlier, the patient was evaluated in a pain management clinic. He had complaints of chest pain that intensified with inspiration, moving, or coughing. He denied any history of previous thoracic trauma. A high‐resolution chest CT scan was requested. The image revealed bilateral fractures of almost all costal arches (Figure [1](#ccr32694-fig-0001){ref-type="fig"}).

![High‐resolution chest CT with evident fractures of costal arches](CCR3-8-559-g001){#ccr32694-fig-0001}

During the outpatient consultation, our observation revealed he was submitted to an adjustable gastric banding 11 years ago with a significant weight loss but with weight regain. Consequently, he was then submitted to Roux‐en‐Y gastric bypass. In the postoperative period of this surgery, the use of antibiotics was necessary to heal an infection of the surgical wound. No other postoperative complications were described. The patient also stated that, at the time of the second surgery, in addition to central obesity, he already had rib cage pain, facial plethora, and easy bruising. No endocrine cause for obesity was studied prior to both surgical procedures. The patient complained of bone pain and significant limitation in gait and daily living activities for several years. Physical examination revealed several signs suggestive of CS: facial plethora, centripetal obesity (Figure [2](#ccr32694-fig-0002){ref-type="fig"}), dorsocervical and supraclavicular fat pads, vinous striae (Figure [2](#ccr32694-fig-0002){ref-type="fig"}), easy bruising, acanthosis nigricans, and proximal myopathy. His endocrine evaluation was consistent with the diagnosis of Cushing\'s disease and the Pituitary Magnetic Resonance demonstrated a macroadenoma with 9.6 × 22.3 mm (Figures [3](#ccr32694-fig-0003){ref-type="fig"} and [4](#ccr32694-fig-0004){ref-type="fig"}) with cavernous sinus invasion. The patient had no complications due to a large compressing macroadenoma. The complementary study also revealed osteoporosis.
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![Pituitary Magnetic Resonance showing a macroadenoma with 9.6 × 22.3 mm](CCR3-8-559-g003){#ccr32694-fig-0003}

![Pituitary Magnetic Resonance showing a macroadenoma with 9.6 × 22.3 mm](CCR3-8-559-g004){#ccr32694-fig-0004}

3. INVESTIGATION {#ccr32694-sec-0003}
================

Chest CT scan revealed bilateral fractures of almost all costal arches (Figure [1](#ccr32694-fig-0001){ref-type="fig"}).

Bone densitometry of the lumbar spine and femur showed a T‐score of −3.4, compatible with osteoporosis.

Laboratory results were consistent with CS and dyslipidemia (Table [1](#ccr32694-tbl-0001){ref-type="table"}). Other laboratory findings were unremarkable, including other hormones produced by the pituitary gland.

###### 

Biochemical results table

  Parameter                                                                      Value
  ------------------------------------------------------------------------------ -----------------------
  Total cholesterol                                                              224 mg/dL (\<200)
  HDL cholesterol                                                                43 mg/dL (\>60)
  Triglycerides                                                                  159 mg/dL (\<150)
  LDL cholesterol                                                                149 mg/dL (\<130)
  24 h urinary free cortisol                                                     686.6 µg/day (36‐137)
  Plasma cortisol after 1‐mg overnight dexamethasone suppression test            20 µg/dL (\<1.8)
  ACTH                                                                           46.3 ρg/mL (10‐60)
  Plasma cortisol after high‐dose dexamethasone suppression test (Liddle test)   
  Baseline                                                                       20 µg/dL
  48 h                                                                           2.4 µg/dL
  Prolactin                                                                      5.3 ng/mL (4‐15.2)
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Pituitary Magnetic Resonance demonstrated a macroadenoma with 9.6 × 22.3 mm (Figures [3](#ccr32694-fig-0003){ref-type="fig"} and [4](#ccr32694-fig-0004){ref-type="fig"}) with cavernous sinus invasion.

4. TREATMENT {#ccr32694-sec-0004}
============

Initially, pharmacological treatment for osteoporosis was initiated with calcium carbonate 500 mg bid, cholecalciferol 400 UI bid, and ibandronic acid 150 mg monthly. Atorvastatin was also prescribed to treat dyslipidemia. The patient underwent transsphenoidal surgery with subtotal removal of the lesion.

Recently, teriparatide 20 mcg id was initiated and ibandronic acid was suspended.

5. OUTCOME AND FOLLOW‐UP {#ccr32694-sec-0005}
========================

Currently, 1 year after surgery, the patient maintains regular follow‐up at the endocrinology clinic and he is analytically free of hypercortisolism, clinically shows a slight improvement in gait and has already lost about 10 kg.

6. DISCUSSION {#ccr32694-sec-0006}
=============

The contribution of bariatric surgery to the treatment of obesity is undeniable.[6](#ccr32694-bib-0006){ref-type="ref"} However, according to most current guidelines, it is essential to make a preoperative evaluation in order to exclude secondary causes of this pathology.[1](#ccr32694-bib-0001){ref-type="ref"} We often come across patients who are evaluated postoperatively without ever having been preoperatively. This case exemplifies that. This patient had several stigmas of the disease that were not recognized until the patient was evaluated by Endocrinology. This highlights the extreme importance of physical examination. Several signs of CS may be present: rounding of the face (moon face), a pad of fatty tissue between the shoulders and neck (buffalo hump), thin skin with bruises and stretch marks, acne, or muscle weakness. This delay in the diagnosis of the disease led to the development of some consequences of CS that could be potentially avoidable, many of which irreversible and with high impact in the daily living activities of the patient.[7](#ccr32694-bib-0007){ref-type="ref"}

Osteoporosis is often associated with CS and, as stipulated in several recommendations, it is indicated to screen for the condition in these patients.[8](#ccr32694-bib-0008){ref-type="ref"} However, it is overlooked at the expense of other comorbidities. In this context, osteoporosis occurs through different mechanisms: decreased intestinal calcium absorption, bone formation and renal calcium reabsorption, and increased bone resorption.[9](#ccr32694-bib-0009){ref-type="ref"} On the contrary, all men diagnosed with osteoporosis should be evaluated for secondary causes of bone loss,[5](#ccr32694-bib-0005){ref-type="ref"} such us CS. Therefore, it is essential that clinicians be aware of the coexistence of both entities and their relationship in order to improve the outcome of the patients.
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